Trial Outcomes & Findings for The Effect of Hypoxia on Type 2 Diabetes and Weight Loss (NCT NCT05147116)

NCT ID: NCT05147116

Last Updated: 2025-01-24

Results Overview

Does 10 days of overnight hypoxia change AUC during a oral glucose tolerance test. Units for AUC are AU (arbitrary units) which have been derived from the trapezoidal method and have been published as such. Trapezoidal method: AUC = Δx ((y0/2)+y1+y2+y3+...+(yn/2)). Due to the study design being a randomised crossover control trial, the results for visits 2 and 3, and, 4 and 5, have been unrandomized into the delta of pre-post hypoxia and sham interventions. Visits 2 and 4 represent baseline compared to visit 3 and 5 respectively.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

22 participants

Primary outcome timeframe

Assessed on all outcome visits (2,3,4&5) across an 8 week period. Δ from pre-post hypoxia visits are calculated and compared to Δ from pre-post sham visits.

Results posted on

2025-01-24

Participant Flow

Participant milestones

Participant milestones
Measure
Hypoxia 15% O2 - Sham (Room Air) 21% O2
Participants will sleep in a tent for 10 nights in hypoxia. They will then have a 3 month washout, crossover and do another 10 nights but in normoxia.
Sham (Room Air) 21% 02 - Hypoxia 15% O2
Participants will sleep in a tent for 10 nights in normoxia. They will then have a 3 month washout, crossover and do another 10 nights but in hypoxia.
Overall Study
STARTED
8
6
Overall Study
COMPLETED
8
5
Overall Study
NOT COMPLETED
0
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Hypoxia 15% O2 - Sham (Room Air) 21% O2
Participants will sleep in a tent for 10 nights in hypoxia. They will then have a 3 month washout, crossover and do another 10 nights but in normoxia.
Sham (Room Air) 21% 02 - Hypoxia 15% O2
Participants will sleep in a tent for 10 nights in normoxia. They will then have a 3 month washout, crossover and do another 10 nights but in hypoxia.
Overall Study
Withdrawal by Subject
0
1

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Total
n=13 Participants
As this is a within-subject, repeated measures RCT, participant characteristics are presented as one.
Age, Continuous
64 years
STANDARD_DEVIATION 9 • n=13 Participants
Sex: Female, Male
Female
4 Participants
n=13 Participants
Sex: Female, Male
Male
9 Participants
n=13 Participants
Region of Enrollment
United Kingdom
13 Participants
n=13 Participants
Height
1.72 m
STANDARD_DEVIATION 0.09 • n=13 Participants
Mass
87.5 kg
STANDARD_DEVIATION 14.6 • n=13 Participants
BMI
29.7 kg/m2
STANDARD_DEVIATION 3.9 • n=13 Participants
HbA1c
61.1 mmol/mol
STANDARD_DEVIATION 14.1 • n=13 Participants
T2DM duration
9.3 years
STANDARD_DEVIATION 7 • n=13 Participants
SBP
132 mmHg
STANDARD_DEVIATION 13 • n=13 Participants
DBP
80 mmHg
STANDARD_DEVIATION 11 • n=13 Participants

PRIMARY outcome

Timeframe: Assessed on all outcome visits (2,3,4&5) across an 8 week period. Δ from pre-post hypoxia visits are calculated and compared to Δ from pre-post sham visits.

Does 10 days of overnight hypoxia change AUC during a oral glucose tolerance test. Units for AUC are AU (arbitrary units) which have been derived from the trapezoidal method and have been published as such. Trapezoidal method: AUC = Δx ((y0/2)+y1+y2+y3+...+(yn/2)). Due to the study design being a randomised crossover control trial, the results for visits 2 and 3, and, 4 and 5, have been unrandomized into the delta of pre-post hypoxia and sham interventions. Visits 2 and 4 represent baseline compared to visit 3 and 5 respectively.

Outcome measures

Outcome measures
Measure
Hypoxia 15% O2
n=11 Participants
Participants will sleep in a tent for 10 nights in hypoxia. Sleeping in a tent: Participants will spend 10 consecutive nights of sleeping in a tent
Sham (Room Air) 21% O2
n=11 Participants
Participants will sleep in a tent for 10 nights in normoxia. Sleeping in a tent: Participants will spend 10 consecutive nights of sleeping in a tent
Δ Mean AUC (Area Under the Curve) Plasma [Glucose]
-17.7 mmol.min.L-1
Standard Deviation 237.7
54.9 mmol.min.L-1
Standard Deviation 226.1

SECONDARY outcome

Timeframe: Assessed on all outcome visits (2,3,4&5) across an 8 week period. Δ from pre-post hypoxia visits are calculated and compared to Δ from pre-post sham visits.

Population: Within-subject cross-over trial. Total still did not exceed 13.

Does 10 days of overnight hypoxia change body mass - assessed via DXA. Due to the study design being a randomised crossover control trial, the results for visits 2 and 3, and, 4 and 5, have been unrandomized into the delta of pre-post hypoxia and sham interventions. Visits 2 and 4 represent baseline compared to visit 3 and 5 respectively.

Outcome measures

Outcome measures
Measure
Hypoxia 15% O2
n=13 Participants
Participants will sleep in a tent for 10 nights in hypoxia. Sleeping in a tent: Participants will spend 10 consecutive nights of sleeping in a tent
Sham (Room Air) 21% O2
n=12 Participants
Participants will sleep in a tent for 10 nights in normoxia. Sleeping in a tent: Participants will spend 10 consecutive nights of sleeping in a tent
Δ Body Mass
0 kg
Standard Deviation 0.9
-0.7 kg
Standard Deviation 1

SECONDARY outcome

Timeframe: Assessed on all outcome visits (2,3,4&5) across an 8 week period. Δ from pre-post hypoxia visits are calculated and compared to Δ from pre-post sham visits.

Population: Within-subject crossover trial. Therefore total is still 10.

Does 10 days of overnight hypoxia change physical activity - assessed via wrist worn accelerometry. Due to the study design being a randomised crossover control trial, the results for visits 2 and 3, and, 4 and 5, have been unrandomized into the delta of pre-post hypoxia and sham interventions. Visits 2 and 4 represent baseline compared to visit 3 and 5 respectively.

Outcome measures

Outcome measures
Measure
Hypoxia 15% O2
n=10 Participants
Participants will sleep in a tent for 10 nights in hypoxia. Sleeping in a tent: Participants will spend 10 consecutive nights of sleeping in a tent
Sham (Room Air) 21% O2
n=10 Participants
Participants will sleep in a tent for 10 nights in normoxia. Sleeping in a tent: Participants will spend 10 consecutive nights of sleeping in a tent
Δ Total Minutes of Physical Activity (Light, Moderate, Moderate to Vigorous Physical Activity).
170 min
Interval 103.0 to 237.0
183 min
Interval 116.0 to 250.0

SECONDARY outcome

Timeframe: Assessed on all outcome visits (2,3,4&5) across an 8 week period. Δ from pre-post hypoxia visits are calculated and compared to Δ from pre-post sham visits.

Population: Within-subject crossover trial. Therefore total is still 10.

Does 10 days of overnight hypoxia change sleep - assessed via wrist worn accelerometry. Due to the study design being a randomised crossover control trial, the results for visits 2 and 3, and, 4 and 5, have been unrandomized into the delta of pre-post hypoxia and sham interventions. Visits 2 and 4 represent baseline compared to visit 3 and 5 respectively.

Outcome measures

Outcome measures
Measure
Hypoxia 15% O2
n=10 Participants
Participants will sleep in a tent for 10 nights in hypoxia. Sleeping in a tent: Participants will spend 10 consecutive nights of sleeping in a tent
Sham (Room Air) 21% O2
n=10 Participants
Participants will sleep in a tent for 10 nights in normoxia. Sleeping in a tent: Participants will spend 10 consecutive nights of sleeping in a tent
Δ Sleep Efficiency (Percentage of Time Spent Asleep While in Bed)
88 % of time spent asleep while
Interval 79.0 to 97.0
86 % of time spent asleep while
Interval 78.0 to 94.0

SECONDARY outcome

Timeframe: Assessed on all outcome visits (2,3,4&5) across an 8 week period. Δ from pre-post hypoxia visits are calculated and compared to Δ from pre-post sham visits.

Population: Within-subject crossover trial. Therefore total is still 12.

Does 10 days of overnight hypoxia change IL-6. Due to the study design being a randomised crossover control trial, the results for visits 2 and 3, and, 4 and 5, have been unrandomized into the delta of pre-post hypoxia and sham interventions. Visits 2 and 4 represent baseline compared to visit 3 and 5 respectively.

Outcome measures

Outcome measures
Measure
Hypoxia 15% O2
n=12 Participants
Participants will sleep in a tent for 10 nights in hypoxia. Sleeping in a tent: Participants will spend 10 consecutive nights of sleeping in a tent
Sham (Room Air) 21% O2
n=12 Participants
Participants will sleep in a tent for 10 nights in normoxia. Sleeping in a tent: Participants will spend 10 consecutive nights of sleeping in a tent
Δ IL-6
1.06 pg/mL
Interval -1.66 to 3.78
-0.55 pg/mL
Interval -2.08 to 0.98

SECONDARY outcome

Timeframe: Assessed on all outcome visits (2,3,4&5) across an 8 week period. Δ from pre-post hypoxia visits are calculated and compared to Δ from pre-post sham visits.

Population: Within-subject crossover trial. Therefore total is still 12.

Does 10 days of overnight hypoxia change TNFɑ. Due to the study design being a randomised crossover control trial, the results for visits 2 and 3, and, 4 and 5, have been unrandomized into the delta of pre-post hypoxia and sham interventions. Visits 2 and 4 represent baseline compared to visit 3 and 5 respectively.

Outcome measures

Outcome measures
Measure
Hypoxia 15% O2
n=12 Participants
Participants will sleep in a tent for 10 nights in hypoxia. Sleeping in a tent: Participants will spend 10 consecutive nights of sleeping in a tent
Sham (Room Air) 21% O2
n=12 Participants
Participants will sleep in a tent for 10 nights in normoxia. Sleeping in a tent: Participants will spend 10 consecutive nights of sleeping in a tent
Δ TNFɑ
0.66 pg/mL
Interval -2.06 to 3.38
0.61 pg/mL
Interval -1.75 to 2.97

Adverse Events

Hypoxia 15% O2

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Sham (Room Air) 21% O2

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr Anthony Shepherd

University of Portsmouth

Phone: 02392845289

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place